Drugs Made In America Acquisition Corp. Financial Overview
Drugs Made In America Acquisition Corp.'s market cap is currently $347.24M. The company's EPS TTM is $; its P/E ratio is 61.48; Drugs Made In America Acquisition Corp. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.